Business (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Deals
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Deals
EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake
Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.
Bonafide Women’s Health Acquires SAM-e Formulation With High Bioavailability
Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.
HRA Brings Mederma Scar-Care Brand To UK
British consumers can now buy three Mederma scar-care products in the UK via Amazon and Superdrug thanks to a recent launch by France's HRA Pharma.
Strategy
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Business Strategies
GSK Prevents UK Strike With Improved Pay Deal
GlaxoSmithKline has averted a strike at its sites across the UK after an improved pay offer was accepted by workers.
Colgate Sees Toothpaste Growth Opportunity In Under-Brushing Countries
“If you took all of these markets where people brush their teeth less than one time a day and just moved it to one time a day, you would increase the volume size of the category by 40%,” noted Colgate-Palmolive’s John Faucher in a 19 May presentation at the Goldman Sachs Global Staples Forum.
People On The Move: Appointments At Alliance Pharma, Venture Life, Maxwellia
A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.
Sales & Earnings
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Sales & Earnings
EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake
Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.
USANA Lowers Guidance After 15% Q1 Sales Drop; Mannatech Reports Nearly $1M Undelivered Goods
Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.
Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
Litigation
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Legal Issues
GSK Prevents UK Strike With Improved Pay Deal
GlaxoSmithKline has averted a strike at its sites across the UK after an improved pay offer was accepted by workers.
Proposal For J&J To Halt Talc Powder Sales Worldwide Fails In Shareholder Vote
Activist investment group Tulipshare’s proposal that J&J fully cease sales of talc-based powders didn’t receive a majority of votes in favor during firm's annual meeting and won’t be forwarded for board’s consideration. Separate proposal for an audit into whether firm marketed products to minority women asbestos concerns was sent to the board.
US Omega-3 Supplement Firm Changes Claims On Amarin Challenge, But Not Label Or Company Name
National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.